Can Relay Therapeutics, Inc. cover its short-term obligations?

Its current ratio is 22.13 — current assets exceed current liabilities.

Where does Relay Therapeutics, Inc.'s balance sheet data come from?

Every line is extracted from Relay Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Relay Therapeutics, Inc. RLAY Balance Sheet Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY

Simplified Detailed

	FY'25	FY'24	FY'23	FY'22
Cash and cash equivalents	$84.02M-32.4%	$124.29M-13.5%	$143.74M-5.3%	$151.79M-45.8%
Restricted cash	$1.34M-37.0%	$2.12M-21.7%	$2.71M+5.0%	$2.58M0.0%
Prepaid expenses and other current assets	$17.79M+2.5%	$17.35M+3.9%	$16.7M+37.9%	$12.11M-8.5%
Total current assets	$578.28M-28.5%	$809.2M+5.1%	$770.1M-24.5%	$1.02B+4.4%
Property and equipment, net	$1.73M-70.8%	$5.91M-45.8%	$10.9M-6.3%	$11.63M+77.8%
Operating lease right-of-use assets	$39.99M-22.7%	$51.76M-10.7%	$57.97M-9.1%	$63.75M+207%
Long-term investments	$470.5M-28.4%	$657.04M+8.4%	$606.35M-28.4%	$847.12M+25.0%
Total assets	$621.33M-28.7%	$871.3M+3.2%	$843.98M-23.3%	$1.1B+9.1%
Accrued expenses	$463K-76.7%	$1.99M+65.3%	$1.2M-95.4%	$26.15M+6,504%
Operating lease liabilities, current	$3.77M-34.3%	$5.73M+15.4%	$4.96M+16.1%	$4.28M+132%
Total current liabilities	$25.58M-49.6%	$50.73M+67.6%	$30.27M-52.5%	$63.71M+162%
Operating lease liabilities, non-current	$28.69M-32.9%	$42.78M-11.8%	$48.5M-9.3%	$53.47M+154%
Total liabilities	$54.27M-42.0%	$93.5M+1.7%	$91.98M-38.5%	$149.55M+35.2%
Preferred stock	——	——	——	——
Common stock	$168K0.0%	$168K+32.3%	$127K+5.0%	$121K+11.0%
Additional paid-in capital	$2.58B+2.5%	$2.52B+16.9%	$2.15B+6.6%	$2.02B+21.1%
Retained earnings	-$2.01B-15.9%	-$1.74B-24.1%	-$1.4B-32.3%	-$1.06B-37.8%
Accumulated other comprehensive income (loss)	$733K+174%	-$991K-406%	-$196K+98.1%	-$10.42M-858%
Total stockholders' equity	$567.06M-27.1%	$777.79M+3.4%	$752M-20.9%	$950.22M+5.8%
Total liabilities and stockholders' equity	$621.33M-28.7%	$871.3M+3.2%	$843.98M-23.3%	$1.1B+9.1%
Other current assets	$5.97M-43.3%	$10.53M+218%	$3.32M+1.7%	$3.26M+84.8%
Net Investment in Lease	$39.99M-22.7%	$51.76M-10.7%	$57.97M-9.1%	$63.75M+207%
Investments	$470.5M-28.4%	$657.04M+8.4%	$606.35M-28.4%	$847.12M+25.0%
Operating lease right-of-use assets	$39.99M-22.7%	$51.76M-10.7%	$57.97M-9.1%	$63.75M+207%
Operating Lease Right-of-Use Assets in Other Assets	$39.99M-22.7%	$51.76M-10.7%	$57.97M-9.1%	$63.75M+207%
Other Commercial Liabilities	$13.65M-35.7%	$21.24M+42.6%	$14.89M-34.4%	$22.7M+67.5%
Accrued Liabilities, Current	$13.65M-35.7%	$21.24M+42.6%	$14.89M-34.4%	$22.7M+67.5%
Other accrued liabilities	$463K-76.7%	$1.99M+65.3%	$1.2M-95.4%	$26.15M+6,504%
Total debt	$32.46M-33.1%	$48.5M-9.3%	$53.47M-7.4%	$57.74M+152%
Common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively	$168K0.0%	$168K+32.3%	$127K+5.0%	$121K+11.0%
Prepaid expenses	$17.79M+2.5%	$17.35M+3.9%	$16.7M+37.9%	$12.11M+5.6%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Can Relay Therapeutics, Inc. cover its short-term obligations?: Its current ratio is 22.13 — current assets exceed current liabilities.
Where does Relay Therapeutics, Inc.'s balance sheet data come from?: Every line is extracted from Relay Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.